We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





Zeesan Biotech Displays DNA Automated Extraction System

By LabMedica International staff writers
Posted on 05 Feb 2018
Zeesan Biotech (Fujian, China) displayed its DNA automated extraction system and real-time PCR kits for MDR/XDR-TB, HPV, HBB, etc. More...
at MEDLAB Middle East, the world’s largest attended laboratory and IVD exhibition and conference.
 
Zeesan is a biomedical company specializing in the development and production of molecular diagnostics related kits, instruments and reagents. The company’s product range includes the MeltPro series of molecular diagnostics products, automated DNA extraction machines and visible-light gel electrophoresis systems. At the MEDLAB Middle East 2018 held in Dubai, UAE, from February 5-8, 2018, Zeesan exhibited its Lab-Aid 824 nucleic acid extraction system, which enables automated, fast, reliable isolation and purification of high-quality nucleic acids for up to 24 samples per run. The entire extraction process is controlled by software and the system is intended for in vitro diagnostic use to provide high quality nucleic acid suitable for direct use in downstream application, such as amplification or other enzymatic reactions.
 
Visitors at Zeesan’s stand at the event also viewed the company’s wide range of real-time PCR kits for MDR/XDR-TB, HPV, HBB, etc. The company’s MeltPro High Risk HPV Genotyping Assay is a qualitative in vitro test kit used for HPV genotyping using cervical cells collected by swab, TCT or LCT. The test utilizes Polymerase Chain Reaction (PCR) for DNA amplification and nucleic acid hybridization for the detection of low-risk HPV types in one reaction. The MeltPro HBB test kit is meant for the detection of 12 gene mutations common in the Pakistani population, which are related to β –Thalassemia and is used for β-Thalassemia screening based on polymerase chain reaction and nucleic acid hybridization. 
 

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Serological Pipet Controller
PIPETBOY GENIUS
New
Clostridium Difficile Toxin A+B Combo Card Test
CerTest Clostridium Difficile Toxin A+B
New
Modular Hemostasis Automation Solution
CN Track
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The RNA-seq based diagnostic test for pediatric leukemia ensures better outcomes for children with this common cancer (Photo courtesy of Qlucore)

RNA-Seq Based Diagnostic Test Enhances Diagnostic Accuracy of Pediatric Leukemia

A new unique test is set to reshape the way Acute Lymphoblastic Leukemia (BCP-ALL) samples can be analyzed. Qlucore (Lund, Sweden) has launched the first CE-marked RNA-seq based diagnostic test for pediatric... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.